Login / Signup

A Pharmacovigilance Analysis of Daptomycin Use Based on CLSI Susceptible Dose-Dependent Category.

Ming M ZhangRyan W StevensJennifer L AdemaKristin C MaraAudrey N SchuetzAaron J TandeChristina G Rivera
Published in: Infectious diseases and therapy (2023)
High-dose daptomycin was not associated with increased laboratory abnormalities or adverse drug reactions compared to standard-dose daptomycin.
Keyphrases
  • adverse drug
  • methicillin resistant staphylococcus aureus
  • high dose
  • electronic health record
  • emergency department
  • low dose
  • drug induced
  • staphylococcus aureus
  • stem cell transplantation